Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.
作者信息
Archbold R A, Timmis A D
机构信息
Department of Cardiology, London Chest Hospital, UK.
出版信息
Heart. 1998 Dec;80(6):543-7. doi: 10.1136/hrt.80.6.543.
Abstract
摘要
相似文献
1
Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.降低胆固醇与冠状动脉疾病：降低风险的机制
Heart. 1998 Dec;80(6):543-7. doi: 10.1136/hrt.80.6.543.
2
Cholesterol lowering and the vessel wall: new insights and future perspectives.胆固醇降低与血管壁：新见解与未来展望。
Physiol Res. 2001;50(5):461-71.
3
Multiple complex coronary plaques in patients with acute myocardial infarction.急性心肌梗死患者的多个复杂冠状动脉斑块
N Engl J Med. 2001 Feb 15;344(7):527-8. doi: 10.1056/NEJM200102153440713.
4
[High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].[大幅降低血脂可使冠状动脉斑块消融——冠心病可逆转吗？]
MMW Fortschr Med. 2006 Jun 15;148(24):4-5.
5
[Improvement of coronary prognosis by reducing LDL-cholesterol].通过降低低密度脂蛋白胆固醇改善冠状动脉预后
Versicherungsmedizin. 1990 Jun 1;42(3):88-91.
6
Lowering of LDL cholesterol.降低低密度脂蛋白胆固醇。
Lancet. 2000 Jan 15;355(9199):235. doi: 10.1016/S0140-6736(05)72112-7.
7
Goals for cholesterol lowering.
Circulation. 1999 May 11;99(18):2477.
8
Cholesterol-lowering and vascular reactivity in relation to coronary heart disease.与冠心病相关的胆固醇降低和血管反应性
Nutr Metab Cardiovasc Dis. 1999 Jun;9(3):133-42.
9
Why cholesterol as a central theme in coronary artery disease?为什么胆固醇是冠状动脉疾病的核心主题？
Am J Cardiol. 1998 Nov 26;82(10B):14T-17T. doi: 10.1016/s0002-9149(98)00717-6.
10
Primary prevention of coronary artery disease.冠状动脉疾病的一级预防
N Engl J Med. 2007 Oct 11;357(15):1543-5. doi: 10.1056/NEJMe078183.
引用本文的文献
1
Therapeutic mechanisms of ginseng in coronary heart disease.人参在冠心病中的治疗机制。
Front Pharmacol. 2023 Oct 3;14:1271029. doi: 10.3389/fphar.2023.1271029. eCollection 2023.
2
Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.阿托伐他汀可降低乌干达接受抗逆转录病毒治疗但免疫反应欠佳的HIV感染者的T细胞激活和耗竭：一项随机交叉安慰剂对照试验。
Trop Med Int Health. 2015 Mar;20(3):380-90. doi: 10.1111/tmi.12442. Epub 2015 Jan 6.
3
Statins improve human coronary atherosclerotic plaque morphology.他汀类药物可改善人类冠状动脉粥样硬化斑块形态。
Tex Heart Inst J. 2008;35(2):99-103.
4
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.他汀类药物治疗的多效性：分子机制与临床结果
Trends Mol Med. 2008 Jan;14(1):37-44. doi: 10.1016/j.molmed.2007.11.004.
本文引用的文献
1
Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study.高胆固醇血症患者降脂治疗后一氧化氮生物利用度增加：一项随机、安慰剂对照、双盲研究。
Circulation. 1998 Jul 21;98(3):211-6. doi: 10.1161/01.cir.98.3.211.
2
N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?N-乙酰半胱氨酸降低巨噬细胞源性泡沫细胞的基质降解能力：抗氧化治疗的新靶点？
Circulation. 1998 Jun 23;97(24):2445-53. doi: 10.1161/01.cir.97.24.2445.
3
Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.饮食降脂可降低兔动脉粥样硬化斑块的基质金属蛋白酶活性并增加胶原蛋白含量：病变稳定的潜在机制。
Circulation. 1998 Jun 23;97(24):2433-44. doi: 10.1161/01.cir.97.24.2433.
4
Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.普伐他汀对动脉粥样硬化猴子的动脉壁有独立于降胆固醇的作用。
J Am Coll Cardiol. 1998 Mar 1;31(3):684-91. doi: 10.1016/s0735-1097(97)00537-8.
5
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.肺炎衣原体感染会加速动脉粥样硬化的发展，而在兔模型中，用阿奇霉素治疗可预防这种情况。
Circulation. 1998 Feb 24;97(7):633-6. doi: 10.1161/01.cir.97.7.633.
6
Biology of the endothelium.内皮细胞生物学
Clin Cardiol. 1997 Nov;20(11 Suppl 2):II-3-10.
7
When 'normal' cholesterol levels injure the endothelium.
Circulation. 1997 Nov 18;96(10):3255-7.
8
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.罗红霉素治疗非Q波冠状动脉综合征的随机试验：ROXIS初步研究。ROXIS研究组
Lancet. 1997 Aug 9;350(9075):404-7. doi: 10.1016/s0140-6736(97)07201-2.
9
Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine.维持内源性抗氧化活性及抑制脂质过氧化作为维生素E、洛伐他汀和氨氯地平抗动脉粥样硬化作用的共同机制。
J Am Coll Cardiol. 1997 Aug;30(2):569-75. doi: 10.1016/s0735-1097(97)00158-7.
10
Endothelial dysfunction: does it matter? Is it reversible?内皮功能障碍：重要吗？可逆吗？
J Am Coll Cardiol. 1997 Aug;30(2):325-33. doi: 10.1016/s0735-1097(97)00189-7.
Zotero 插件